Adult-onset Still’s disease triggered by pregnancy by Abdulkarim, Saleem et al.
eCommons@AKU
Internal Medicine, East Africa Medical College, East Africa
March 2019
Adult-onset Still’s disease triggered by pregnancy
Saleem Abdulkarim
Aga Khan University, saleem.abdulkarim@aku.edu
Fredrick Otieno
Aga Khan University, fredrick.otieno@aku.edu
Sayed Karar
Aga Khan University, sayed.karar@aku.edu
Follow this and additional works at: https://ecommons.aku.edu/eastafrica_fhs_mc_intern_med
Part of the Internal Medicine Commons
Recommended Citation
Abdulkarim, S., Otieno, F., Karar, S. (2019). Adult-onset Still’s disease triggered by pregnancy. Baylor University Medical Center
Proceedings, 1-2.
Available at: https://ecommons.aku.edu/eastafrica_fhs_mc_intern_med/97
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=ubmc20
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
ISSN: 0899-8280 (Print) 1525-3252 (Online) Journal homepage: https://www.tandfonline.com/loi/ubmc20
Adult-onset Still’s disease triggered by pregnancy
Saleem Abdulkarim, Fredrick Otieno & Sayed K. Ali
To cite this article: Saleem Abdulkarim, Fredrick Otieno & Sayed K. Ali (2019): Adult-onset
Still’s disease triggered by pregnancy, Baylor University Medical Center Proceedings, DOI:
10.1080/08998280.2018.1562292
To link to this article:  https://doi.org/10.1080/08998280.2018.1562292
Published online: 27 Mar 2019.
Submit your article to this journal 
View Crossmark data
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ABSTRACT
Adult-onset Still’s disease (AOSD) is an inflammatory disorder with arthritis, quotidian fever, evanescent rash, elevated white cell
count, elevated ferritin, and abnormal liver function tests. The diagnosis requires the exclusion of other inflammatory, infectious,
and malignant conditions. Onset of AOSD, though rare, has been known to occur in pregnancy. We present a 28-year-old
woman diagnosed with AOSD at 3 months gestation.
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A
dult-onset Still’s disease (AOSD) is an inflamma-
tory condition characterized clinically by quotidian
fever, arthritis, and an evanescent rash associated
with an elevated white cell count with neutrophilia,
elevated ferritin levels, and abnormal liver function tests. It is
a rare condition with an incidence reported in a retrospective
French study of 0.16 per 100,000.1 The incidence of onset of
AOSD in pregnancy is even less frequent, with a literature
review revealing 20 reported cases to date.2 The exact etiopa-
thogenesis of the condition is not clear, but a variety of infec-
tious causes on a background of genetically predisposed
individuals is believed to play a role.3–7 The diagnosis of
AOSD requires exclusion of inflammatory, infectious, and
malignant conditions. The Yamaguchi criteria, which include
clinical and laboratory parameters, are commonly used to help
make the diagnosis.8
CASE PRESENTATION
A 28-year-old woman, para 2þ 0 gravida 3, at 12 weeks
gestation by dates with no prior medical comorbidities pre-
sented to our institution with a 2-week history of joint pain.
She noted pain, swelling, and stiffness of the ankles, knees,
wrists, elbows, and shoulders bilaterally with associated limi-
tation of movement. She also reported daily fever with onset
in the evening and a sore throat. She denied having a rash,
oral ulcers, or alopecia. She had completed two courses of
oral antibiotics (amoxicillin/clavulanic acid and cefuroxime)
for presumed infection at an external facility where she was
noted to have fevers of up to 39C with no clear focus of
infection. On examination, she had tender joints in the dis-
tribution described but no palpable hepatomegaly or spleno-
megaly. Her hemoglobin was 11.2 g/dL; white cell count,
19.13 109/L (neutrophils 85%); platelets, 322 109/L; C-
reactive protein, 363 mg/L; erythrocyte sedimentation rate,
60mm/h; procalcitonin, 0.25 ng/mL; ferritin, 5306 ng/mL;
and antinuclear antibodies, rheumatoid factor, and anticyclic
citrullinated peptide were negative. A complete metabolic
panel, including liver function tests, was normal. Blood and
urine cultures were negative. Tests for malaria, syphilis, den-
gue virus, leptospirosis, rickettsia, West Nile virus, and
Chikungunya virus were also negative. An HIV test was
nonreactive. The patient was subsequently started on
steroids with intravenous methylprednisolone at 250 mg
with improvement of her symptoms. She did not receive
intravenous immunoglobulin. She was discharged on day 2
with complete resolution of her fevers and joint pain on
prednisone 20 mg twice a day.
She returned to our institution 9 weeks later (at 21 weeks
gestation) and was noted to be jaundiced and have abnormal
liver function tests (alanine aminotransferase, 1137 U/L;
aspartate aminotransferase, 974 U/L; alkaline phosphatase,
173 U/L; gamma glutamyl transferase, 564 U/L; total biliru-
bin, 210 lmol/L; direct bilirubin, 200 lmol/L). Hepatitis A,
B, and C serologies were negative. An autoimmune hepatitis
panel, including anti-smooth muscle, anti-mitochondrial,
and anti-ds-DNA antibodies, was also negative. Magnetic
retrograde cholangiopancreatography was normal. This was
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considered a flare-up of her AOSD. She was started on
intravenous methylprednisolone 500 mg once a day with
improvement in her liver function tests (alanine amino
transferase, 897 U/L; aspartate aminotransferase, 878 U/L;
alkaline phosphatase, 143 U/L; gamma glutamyl transferase,
476 U/L; total bilirubin, 183 lmol/L; direct bilirubin, 175
lmol/L). She was discharged on day 3 with prednisone 20
mg once a day and azathioprine 50 mg once a day. She was
doing well during follow-up at 38 weeks gestation with
normal liver function. Her maintenance medications
included prednisone 10 mg twice a day and azathioprine
100 mg once a day.
DISCUSSION
AOSD onset during pregnancy remains rare.2 AOSD
demonstrates a bimodal age distribution with peaks at 15 to
25 and 36 to 46 years of age.9 The age distribution in a case
series published locally was between 21 and 48 years (mean
age, 35).9 The pattern of presentation of our patient was
similar to that reported in a case series of patients with onset
of AOSD in pregnancy with fever, arthralgia, and sore
throat2; 80% of those patients were noted to have a rash,
which was not noted in our patient, though the rash may be
more difficult to detect in dark-skinned individuals. Of note
is that all patients in the series had systemic involvement,
and none presented with a chronic articular form. The gesta-
tional age of onset was noted to be in the first or second tri-
mester (8 to 26 weeks), with our patient having onset of
symptoms at 10 weeks with a diagnosis made at 12 weeks.
Ferritin levels were elevated in all patients, ranging from
1311 to 41,424 ng/mL. Flares in the patients appeared
between the first and second trimesters, earlier than in
patients with preexisting AOSD.10 Obstetric complications
seemed to be common, with 50% of the women having pre-
term births and 15% complicated by intrauterine growth
restriction.10
Treatment of AOSD can be challenging. Steroids are
usually utilized but carry the risk of gestational diabetes,
hypertension, and frequent monitoring. Intravenous
immunoglobulin may be used in life-threatening cases.11
Azathioprine is sometimes preferred due to its steroid-sparing
property.12 Cases reported of the condition in pregnancy
remain few and treatment experience so far is derived from
case series.
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